Biotech Values

[poorgradstudent]

While i question my understanding of the science , i feel that the lack of interest from this board is almost a negative for owning the stock....and i resigned myself to just post info gleaned on other boards in case some find it usefull here

Or it could be that there are too many companies to research and follow.

The other problem, for someone like me, is that the trend is to assess companies / drugs earlier and earlier nowadays. So unless you have some very strong insight / background, getting in at the preclinical or phase I state is a crapshoot.